Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Brederode S.A. | BREB | Apr 23, 2024 | 111.40 | +0.36 |
Campine nv | CAMB | Apr 23, 2024 | 74.50 | +2.05 |
Candela Invest | CAND | Apr 23, 2024 | 2.90 | 0.00 |
Care Property Invest NV/SA | CPINV | Apr 23, 2024 | 13.50 | +1.81 |
Celyad Oncology SA | CYAD | Apr 23, 2024 | 0.33 | +3.13 |
Cenergy Holdings | CENER | Apr 23, 2024 | 7.45 | -0.13 |
Chevron | CHTEX | Apr 23, 2024 | 170.32 | 0.00 |
Choice NV | MLTV | Apr 23, 2024 | 1.49 | 0.00 |
Cisco Systems | CIS | Apr 23, 2024 | 53.06 | 0.00 |
Cofinimmo | COFB | Apr 23, 2024 | 63.20 | +0.40 |
Cofinimmo PRF PERPETUAL EUR | COFP1 | Apr 23, 2024 | 127.00 | 0.00 |
Cofinimmo PRF PERPETUAL EUR - Registered 0% | COFP2 | Apr 23, 2024 | 95.00 | 0.00 |
Colruyt Group N.V. | COLR | Apr 23, 2024 | 42.84 | +0.56 |
Compagnie du Bois Sauvage S.A. | COMB | Apr 23, 2024 | 248.00 | -1.20 |
Compagnie d`Entreprises CFE SA | CFEB | Apr 23, 2024 | 7.62 | +0.93 |
Connect Group | CONN | Apr 23, 2024 | 1.53 | 0.00 |
Crescent NV | OPTI | Apr 23, 2024 | 0.01 | +4.62 |
Cumulex NV | CLEX | Apr 23, 2024 | 1.15 | 0.00 |
CURETIS | CURE | Apr 23, 2024 | 0.29 | 0.00 |
Deceuninck NV. | DECB | Apr 23, 2024 | 2.54 | +0.59 |
Deme Group N.V. | DEME | Apr 23, 2024 | 147.00 | +1.24 |
Deutsche Telekom AG | DTEL | Apr 23, 2024 | 20.00 | 0.00 |
Dexia SA | DEXB | Apr 23, 2024 | 0.30 | 0.00 |
Diegem KennedyCert | DIEG | Apr 23, 2024 | 120.00 | 0.00 |
Distri Land Le Certificat Foncier | DISL | Apr 23, 2024 | 210.00 | 0.00 |
DMS Imaging SA | DMSIM | Apr 23, 2024 | 0.02 | 0.00 |
DMS Imaging SA | ALIMG | Apr 23, 2024 | 0.02 | -1.92 |
D`ieteren Group | DIE | Apr 23, 2024 | 206.00 | +1.28 |
E. On SE | EON | Apr 23, 2024 | 11.32 | 0.00 |
Eckert & Ziegler BEBIG SA | EZBG | 0.00 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.